Scientists have developed a ligand molecule that connects peptide drugs to blood-serum albumin and keeps them from being cleared out by the kidneys too soon. The ligand is easy to synthesize and can extend the half-life of therapeutic peptides from minutes to several days.
Researchers show in proof-of-principle experiments that the CRISPR system, developed further as a first-of-its-kind approach, is able to encode in living cells information as complex as a digitized image of a human hand.
Researchers have discovered how Cpf1, a new molecular scissors unzip and cleave DNA. This member of the CRISPR-Cas family displays a high accuracy, capable of acting like a GPS in order to identify its destination within the intricate map of the genome.